⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TEVA News
Teva Pharmaceutical Industries Limited American Depositary Shares
Teva Continues Biosimilar Momentum with U.S. FDA Approval of DEGEVMA™ (denosumab-adet), a Biosimilar to Xgeva® (denosumab)
globenewswire.com
TEVA
AMGN
CAPR Stock Drop Alert: Capricor Therapeutics Stock Plummets 64% after Clinical Data Issues Revealed – BFA Law Notifies Investors of the Imminent September 28 Deadline
globenewswire.com
CAPR
TSLA
TEVA
Global Nanomedicine Market to Reach USD 581.2 Bn. by 2034, Driven by Rising Chronic Disease Prevalence, Expanding Nanotechnology-Based Drug Delivery, and Advances in Precision Diagnostics and Therapeutics Says Maximize Market Research
prnewswire.com
BMY
TEVA
SNY
Global Multiple Sclerosis Treatment Market to Grow at 5.8% CAGR, Reaching USD 44.45 Billion by 2034 as Advanced Therapies and Disease-Modifying Treatments Gain Momentum, Says Maximize Market Research
prnewswire.com
NVS
BIIB
SNY
MRK
BMY
JNJ
TEVA
VTRS
AMGN
Teva Releases Q3 2026 Aide Memoire
globenewswire.com
TEVA
Teva to Host Conference Call to Discuss Third Quarter 2026 Financial Results on November 3, 2026 at 8 a.m. ET
globenewswire.com
TEVA
Forge’s Fierce Pharma Week Delivered a Powerhouse Event with Over 3,500 Pharmaceutical and Biotech Decision-Makers and Innovators, Representing a 21% Increase in Attendees Over 2025
globenewswire.com
ABBV
ACAD
AZN
BIIB
BMY
LLY
GILD
PFE
REGN
TEVA
$CCB Stock Notification: Coastal Financial is Being Investigated for Securities Fraud after Banking Services Issues Disclosed – Investors are Alerted to Contact BFA Law
globenewswire.com
CCB
TSLA
TEVA
$RXT Stock Notification: Rackspace Technology has been Sued for Securities Fraud after AI Effort Issues Disclosed – Investors are Alerted to Contact BFA Law by September 28
globenewswire.com
RXT
AMD
TSLA
TEVA
BBNX Class Action: Beta Bionics Investors are Notified of the Upcoming November 3 Deadline in Ongoing Securities Fraud Class Action over Medical Device Safety
prnewswire.com
BBNX
TSLA
TEVA